LIMCH1 in Cancer: A Context-Dependent Modulator Beyond the Tumor Suppressor–Oncogene Dichotomy
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188144 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Mengying Guan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, China. Hauptthemen laut MEDLINE: Neoplasms, LIM Domain Proteins, Oncogenes. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yangpu Hospital of Tongji University, Yangpu Hospital Affiliated to Tongji University, Tongji University Affiliated Yangpu Hospital.
Abstract (Originalsprache)
LIM and calponin homology domain-containing protein 1 (LIMCH1) has recently gained attention as a functionally perplexing factor in human cancers, with studies attributing both tumor-suppressive and tumor-promoting properties that defy simple categorization. Originally described as an actin-associated cytoskeletal protein that promotes non-muscle myosin-IIA (NM-IIA) activity and thereby curtails cell migration, LIMCH1 has more recently been linked to diverse oncogenic pathways across a range of tumor types. In lung adenocarcinoma and clear-cell renal cell carcinoma, diminished LIMCH1 expression is associated with more aggressive clinical behavior and reduced overall survival, aligning with a tumor-suppressive role. By comparison, in triple-negative and invasive breast cancers and in cervical squamous cell carcinoma, increased LIMCH1 expression correlates with enhanced metastatic spread, immune escape, and unfavorable outcomes, suggesting a pro-oncogenic function. In this review, findings from over 30 published studies are integrated with an original TCGA pan-cancer expression and survival analysis to propose that LIMCH1 is best understood as a context-dependent conditional regulator rather than as a classical tumor suppressor or oncogene. Based on the available evidence, we propose a hypothesis-generating conceptual framework in which its ultimate phenotypic effect is shaped by three interacting contextual determinants: (i) TP53 mutation status (determining whether the HUWE1-p53 axis is intact); (ii) tumor matrix stiffness (modulating actomyosin contractility and migration mode); and (iii) upstream signaling cues (e.g., MAPK/ERK, TGFβ). Of note, other tumor-lineage and microenvironmental factors may also contribute and warrant further investigation. This framework resolves the apparent functional duality of LIMCH1 in a cancer type-specific manner and provides critical guidance for future mechanistic research, standardized detection workflows, and the clinical translation of LIMCH1-based biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, China.
- Department of Pathology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, China.
ORCID-Profile: Mengying Guan, Hua Hao
Förderung
- Yangpu Hospital of Tongji University
- Yangpu Hospital Affiliated to Tongji University
- Tongji University Affiliated Yangpu Hospital
Zitieren
APA
Guan, M., & Hao, H. (2026). LIMCH1 in Cancer: A Context-Dependent Modulator Beyond the Tumor Suppressor–Oncogene Dichotomy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188144
Vancouver
Guan M, Hao H. LIMCH1 in Cancer: A Context-Dependent Modulator Beyond the Tumor Suppressor–Oncogene Dichotomy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188144
BibTeX
@article{Guan2026,
author = {Guan, Mengying and Hao, Hua},
title = {LIMCH1 in Cancer: A Context-Dependent Modulator Beyond the Tumor Suppressor–Oncogene Dichotomy},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188144}
}
EUVIMED